321 related articles for article (PubMed ID: 10778586)
1. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
Chaddha DS; Kalra SP; Singh AP; Gupta RM; Sanchetee PC
J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation and outcome of toxoplasmic encephalitis in patients with human immunodeficiency virus type 1 infection.
Ho YC; Sun HY; Chen MY; Hsieh SM; Sheng WH; Chang SC
J Microbiol Immunol Infect; 2008 Oct; 41(5):386-92. PubMed ID: 19122919
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system toxoplasmosis in adult Ethiopians.
Amogne W; Teshager G; Zenebe G
Ethiop Med J; 2006 Apr; 44(2):113-20. PubMed ID: 17447372
[TBL] [Abstract][Full Text] [Related]
5. [Azithromycin combined with pyrimethamine in the treatment of neurotoxoplasmosis, in an AIDS patient].
Trotta M; Sterrantino G; Milo D; Dionisio D; Leoncini F
Minerva Med; 1997 Mar; 88(3):117-9. PubMed ID: 9148227
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.
Luft BJ; Hafner R; Korzun AH; Leport C; Antoniskis D; Bosler EM; Bourland DD; Uttamchandani R; Fuhrer J; Jacobson J
N Engl J Med; 1993 Sep; 329(14):995-1000. PubMed ID: 8366923
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
[TBL] [Abstract][Full Text] [Related]
8. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
[TBL] [Abstract][Full Text] [Related]
9. Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994-2006.
Béraud G; Pierre-François S; Foltzer A; Abel S; Liautaud B; Smadja D; Cabié A
Am J Trop Med Hyg; 2009 Apr; 80(4):583-7. PubMed ID: 19346380
[TBL] [Abstract][Full Text] [Related]
10. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy.
Bertschy S; Opravil M; Cavassini M; Bernasconi E; Schiffer V; Schmid P; Flepp M; Chave JP; Christen A; Furrer H;
Clin Microbiol Infect; 2006 Jul; 12(7):666-71. PubMed ID: 16774564
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
Chirgwin K; Hafner R; Leport C; Remington J; Andersen J; Bosler EM; Roque C; Rajicic N; McAuliffe V; Morlat P; Jayaweera DT; Vilde JL; Luft BJ
Clin Infect Dis; 2002 May; 34(9):1243-50. PubMed ID: 11941551
[TBL] [Abstract][Full Text] [Related]
13. Cerebral toxoplasmosis in childhood and adult HIV infection treated with 1-4 hydroxynaphthoquinone and rapid desensitization with pyrimethamine.
Bouboulis DA; Rubinstein A; Shliozberg J; Madden J; Frieri M
Ann Allergy Asthma Immunol; 1995 Jun; 74(6):491-4. PubMed ID: 7788516
[TBL] [Abstract][Full Text] [Related]
14. Oral trimethoprim-sulfamethoxazole in the treatment of cerebral toxoplasmosis in AIDS patients--a prospective study.
Francis P; Patel VB; Bill PL; Bhigjee AI
S Afr Med J; 2004 Jan; 94(1):51-3. PubMed ID: 14971234
[TBL] [Abstract][Full Text] [Related]
15. Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids.
Arens J; Barnes K; Crowley N; Maartens G
S Afr Med J; 2007 Oct; 97(10):956-8. PubMed ID: 18000578
[TBL] [Abstract][Full Text] [Related]
16. Toxoplasmosis of the central nervous system in patients with AIDS in Mexico.
del Rio-Chiriboga C; Orzechowski-Rallo A; Sanchez-Mejorada G
Arch Med Res; 1997; 28(4):527-30. PubMed ID: 9428578
[TBL] [Abstract][Full Text] [Related]
17. [Value of magnetic resonance in the diagnostic definition of neurotoxoplasmosis and in the assessment of the response to pharmacological treatment].
Sparacia G; Brancatelli G; Sarno C; De Maria M; Lagalla R; Filosto L
Radiol Med; 1998; 96(1-2):23-8. PubMed ID: 9819614
[TBL] [Abstract][Full Text] [Related]
18. [Cerebral toxoplasmosis and AIDS in Martinique].
Bourée P; Dumazedier D; Magdeleine C; Sobesky G
Med Trop (Mars); 1997; 57(3):259-61. PubMed ID: 9513153
[TBL] [Abstract][Full Text] [Related]
19. Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings).
Dedicoat M; Livesley N
Cochrane Database Syst Rev; 2006 Jul; (3):CD005420. PubMed ID: 16856096
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for toxoplasmic encephalitis in HIV-infected patients: a case-control study in Brazil.
Nascimento LV; Stollar F; Tavares LB; Cavasini CE; Maia IL; Cordeiro JA; Ferreira MU
Ann Trop Med Parasitol; 2001 Sep; 95(6):587-93. PubMed ID: 11672464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
